4536 — Santen Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapSuper Stock

Annual balance sheet for Santen Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	C2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	91,882	63,415	84,307	58,677	94,961
Net Total Accounts Receivable
Net Total Receivables	86,999	95,992	99,591	107,225	90,539
Total Inventory
Total Other Current Assets
Total Current Assets	218,556	206,231	229,426	213,326	236,139
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	35,601	39,489	56,287	66,173	71,576
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	408,768	405,285	459,976	421,179	435,699
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	67,597	78,549	95,821	89,504	92,796
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	105,903	95,104	122,487	127,199	129,645
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	302,865	310,181	337,489	293,980	306,054
Total Liabilities & Shareholders' Equity	408,768	405,285	459,976	421,179	435,699
Total Common Shares Outstanding